Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVOREN: Avastin + Roferon in mRCC
NCT00738530Phase 3Completed
- Sponsor
- Roche
- Start
- Jun 2004
- Primary completion
- Sep 2008
- Modality
- Monoclonal Antibodies
- Countries
- 18
01
Overview
A Phase 3 trial of bevacizumab in metastatic renal cell carcinoma (mRCC), sponsored by Roche. Started Jun 2004; status: completed.
02
Drugs
bevacizumab
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT00738530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00738530.